Nihon Kohden Corporation

Nihon Kohden Corporation

9.60
USD
+0.12
(+1.27%)
0.47EPS
21.34P/E
1.62BMarket Cap
Feb 04Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
871.13
914.42
944.57
969.9
1,016.81
1,049.03
1,085.46
1,171.69
1,209.17
1,226.34
1,318.73
1,356.05
1,444.7
1,427.99
Basic EPS, GAAP
70.2
63.36
60.01
53.36
53.42
65.66
57.81
107.02
138.14
101.56
101.14
84.81
89.18
74.17
Free Cash Flow per Basic Share
27.78
46.41
18.95
26.54
43.93
38.54
33.01
61.96
134.19
-63.92
64.28
39.56
81.1
126.85
Dividend per Share
14.94
18.78
17.27
17.48
17.48
17.5
17.48
17.48
28.54
34.03
35.45
30.68
32.16
32.23
Book Value per Share
502.96
564.34
569.67
605.93
641.57
681.08
714.45
815.29
925.46
995.37
1,078.36
1,100.25
1,122.59
1,119.08
Tangible Book Value per Share
465.12
525.76
533.56
573.29
611.77
654.32
690.11
801.63
903.35
970.3
1,049.47
930.8
952.56
950.59
Basic Weighted Avg Shares
176
176
175
171
171
170
170
170
170
168
168
166
163
161
Sales/Revenue/Turnover
153,194
160,803
165,522
166,285
174,249
178,799
185,007
199,727
205,129
206,603
221,986
225,424
235,099
230,348
Operating Margin (%)
11.45
9.9
9.93
8.17
8.33
8.41
8.38
13.57
15.11
10.22
8.83
9.19
7.97
6.95
Depreciation Expense
3,240
3,605
3,624
3,564
3,486
3,692
3,745
4,543
3,490
3,791
3,853
4,190
5,821
6,393
Net Income, GAAP
12,346
11,142
10,516
9,149
9,154
11,191
9,854
18,243
23,435
17,110
17,026
14,098
14,513
11,965
Effective Tax Rate (%)
34.98
36.02
33.84
33.95
34.39
27.88
29.51
32.84
31.6
30.77
42.02
34.64
26.9
26.32
Profit Margin (%)
8.06
6.93
6.35
5.5
5.25
6.26
5.33
9.13
11.42
8.28
7.67
6.25
6.17
5.19
Working Capital
65,267
72,735
70,028
74,229
76,086
83,865
88,701
105,532
121,071
125,932
134,432
110,789
128,380
127,572
LT Debt
31
30
29
16
17
17
42
43
24
17
39
38
22,527
21,111
Total Equity
88,508
99,301
97,669
103,885
109,352
116,086
121,773
138,983
156,378
167,602
181,080
181,292
179,822
180,370
Return on Invested Capital (%)
13.02
10.38
10.68
8.64
8.71
9.35
8.93
13.39
13.69
8.76
6.34
6.79
6.56
5.78
Return on Capital (%)
14.76
11.75
10.56
9.03
8.56
9.89
8.26
13.95
15.83
10.54
9.74
7.29
7.13
6.09
Return on Common Equity (%)
15
11.87
10.68
9.08
8.59
9.93
8.29
13.99
15.87
10.56
9.77
7.82
8.08
6.76

Capital Structure

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
ST Debt
2,676
2,605
2,605
LT Borrowings
22,388
21,750
21,111
LT Finance Leases
139
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
160
160
161
Market Capitalization
236,009
228,250
254,990

Working Capital

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
Total Current Assets
177,808
167,306
170,710
Cash, Cash Equivalents & STI
46,695
51,345
59,963
Accounts Receivable, Net
65,973
53,729
51,944
Inventories
55,990
56,173
53,458
Total Current Liabilities
49,428
42,056
43,138
Payables & Accruals
- -
- -
- -
ST Debt
2,676
2,605
2,605
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.39%
5.41%
-0.81%
Free Cash Flow
-0.77%
-34.16%
100.65%
Net Income, GAAP
6.92%
-2.66%
2.94%
Sales/Revenue/Turnover
3.6%
3.34%
4.29%
Total Cash Common Dividend
7.15%
14.62%
2.61%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
46,227
56,557
55,692
66,948
225,424
2026
50,020
58,100
55,893
71,086
235,099
2027
47,405
55,964
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
4.57
-1.82
46.58
36.56
84.81
2026
0.84
26.9
11.57
49.94
89.18
2027
-4.72
17.08
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
15.29
0.22
15.12
0.04
30.68
2026
15.77
0.22
16.09
0.02
32.16
2027
15.86
0.23
- -
- -
- -

Company Description

CEO
Hirokazu Ogino
Full Time Employees
6,116
Sector
Health technology
Industry
Medical specialties
Address
1-31-4 Nishiochiai Tokyo TY Japan 161-8560
IPO Date
Nov 2, 1961
Business
Nihon Kohden Corporation manufactures, develops, sells, maintains, and provides consultation for medical electronic equipment and related systems worldwide. Founded in 1951 and headquartered in Tokyo, Japan, the company operates in over 120 countries across Japan, the Americas, Europe, Asia, and other regions, serving hospitals, clinics, and research facilities with products focused on physiological measurement, patient monitoring, treatment, IT solutions, and laboratory equipment. Its core offerings include electroencephalographs, electrocardiographs, evoked potential/EMG measuring instruments, and polygraphs for cath-labs; patient monitoring systems for emergency rooms, operating rooms, intensive care units, general wards, transport, remote ICU, central nursing, and ambulatory telemetry; defibrillators and automated external defibrillators; imported and in-house ventilators, pacemakers, and ICDs; clinical information systems and diagnostic IT platforms for laboratories, operating rooms, and wards; blood cell counters with reagents; and clinical chemistry analyzers measuring C-reactive protein and HbA1c. In late 2024, Nihon Kohden acquired a 71.4% stake in NeuroAdvanced Corp., parent of Ad-Tech Medical Instrument Corporation, for approximately ¥16 billion to expand its neurology electrode portfolio for epilepsy care, forming a joint venture with seller ArchiMed; in 2025, it agreed to acquire the remaining 28.6% stake for ¥7.4 billion, achieving full ownership. The company launched Nihon Kohden Payment Solutions in May 2025, offering flexible financing terms from 12 to 60 months for healthcare providers to acquire monitoring and diagnostic equipment. It is constructing a new plant in Tsurugashima City, with operations planned to start in 2026 following PLM/MES system implementation completed in October 2025, as part of investments totaling around ¥11 billion.

Company News

  • Analyzing Beta Bionics (NASDAQ:BBNX) and Nihon Kohden (OTCMKTS:NHNKY)

  • Nihon Kohden Expands Executive Leadership to Support Continued Growth and Customer Experience

  • Nihon Kohden Upgrades NKV-550, Now First Ventilator Combining Non-Invasive Muscle Pressure Monitoring, AVM and Adjustable AdaptiveSync™ Manufactured in the U.S.

  • Nihon Kohden (OTCMKTS:NHNKY) versus Nuwellis (NASDAQ:NUWE) Head to Head Contrast

  • Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – What’s Next?

  • Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting